Eli Lilly's Daniel Skovronsky talks the latest orforglipron trial, while UnitedHealth Group CEO Stephen Hemsley is moving quickly on a strategic turnaround.
Original Image Link
Source:www.msn.com
Original Image Link
Source:www.msn.com
Posted: 2025-08-26 12:01:06